Ribosomal protein L22 pseudogene 10 (RPL22P10)

Ribosomal protein L22 pseudogene 10 (RPL22P10) is a processed pseudogene related to the ribosomal protein L22 gene (RPL22). It does not encode a functional protein and is not considered a therapeutic target. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically do not produce functional proteins. The RPL22 gene itself encodes a component of the 60S ribosomal subunit, but RPL22P10, like other processed pseudogenes, does not have protein-coding capacity or direct relevance as a target for drug development[1][3][5]. RPL22P10 is explicitly identified as a pseudogene derived from the RPL22 gene. Pseudogenes do not produce active proteins, enzymes, receptors, or other direct drug targets[3][5]. The canonical ribosomal protein is "60S ribosomal protein L22" (abbreviation: RPL22), which is functional and participates in protein synthesis as part of the ribosome, but its pseudogene forms (including RPL22P10) do not fulfill this role[3][5]. Because this entry is a pseudogene, it is not a therapeutic target and does not fall into groupings like receptor, ion channel, or enzyme. No biomarkers, interacting drugs, disease roles, or safety concerns have been described for RPL22P10; such relationships, if they exist, pertain to the functional parental gene, RPL22. If you intended the functional ribosomal protein gene (RPL22), rather than the pseudogene (RPL22P10), clarify your query to receive details about the true protein-coding gene.

Other names

RPL22P10